Hjem › Alzheimers sygdom › Florida › Ocala
Alzheimers sygdom kliniske forsøg i Ocala, FL
6 studier for Alzheimers sygdom søger deltagere på steder i og omkring Ocala (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
RekruttererFase 2
- Renstar Medical Research, Ocala
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
RekruttererFase 3
- Renstar Medical Research, Ocala
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
RekruttererFase 3
- Local Institution - 1608, Ocala
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
RekruttererFase 2
- Renstar Medical Research ( Site 1012), Ocala
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
RekruttererFase 3
- Renstar Medical Research, Ocala
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
RekruttererFase 2
- Renstar Medical Research, Ocala
Alzheimers sygdom forsøg i andre byer
- Boston, MA26 studier
- Orlando, FL25 studier
- St. Louis, MO22 studier
- New York City, NY21 studier
- Miami, FL20 studier
- Tampa, FL17 studier
- Atlanta, GA16 studier
- Philadelphia, PA15 studier
- Phoenix, AZ15 studier
- The Villages, FL15 studier
- Los Angeles, CA14 studier
- Indianapolis, IN14 studier
Andre studier i Ocala
- Ikke-småcellet lungecancer10 studier
- Steatotisk leversygdom8 studier
- Overvægt7 studier
- Overvægt6 studier
- KOL5 studier
- Hjertesvigt5 studier
- Let kognitiv svækkelse3 studier
- Metastatisk cancer3 studier
- Aterosklerose3 studier
- Kardiovaskulær sygdom3 studier
- Kroniske smerter3 studier
- Leversygdomme3 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.